nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR2—Peptide ligand-binding receptors—F2—liver cancer	0.00824	0.00824	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CHN2—liver cancer	0.00801	0.00801	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IFT88—liver cancer	0.00794	0.00794	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IFT88—liver cancer	0.00733	0.00733	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TRIO—liver cancer	0.00672	0.00672	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—F2—liver cancer	0.00657	0.00657	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CDKN1B—liver cancer	0.00653	0.00653	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CASP3—liver cancer	0.0065	0.0065	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—F2—liver cancer	0.00648	0.00648	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR4—liver cancer	0.00644	0.00644	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CASP3—liver cancer	0.0064	0.0064	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—liver cancer	0.00639	0.00639	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—JUN—liver cancer	0.00632	0.00632	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CHN2—liver cancer	0.00631	0.00631	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00627	0.00627	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCND1—liver cancer	0.00623	0.00623	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TRIO—liver cancer	0.0062	0.0062	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TRIO—liver cancer	0.0061	0.0061	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—liver cancer	0.00605	0.00605	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00599	0.00599	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR4—liver cancer	0.00595	0.00595	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00587	0.00587	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR4—liver cancer	0.00585	0.00585	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IFT88—liver cancer	0.00577	0.00577	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TRIO—liver cancer	0.00563	0.00563	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00552	0.00552	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.00552	0.00552	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR4—liver cancer	0.0054	0.0054	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00512	0.00512	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—liver cancer	0.005	0.005	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—liver cancer	0.00499	0.00499	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—JUN—liver cancer	0.00497	0.00497	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00494	0.00494	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TRIO—liver cancer	0.00488	0.00488	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SHC3—liver cancer	0.00487	0.00487	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—liver cancer	0.00473	0.00473	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR4—liver cancer	0.00468	0.00468	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—liver cancer	0.00466	0.00466	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—F2—liver cancer	0.00456	0.00456	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SHC3—liver cancer	0.00449	0.00449	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TRIO—liver cancer	0.00444	0.00444	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00441	0.00441	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00435	0.00435	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.00434	0.00434	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR4—liver cancer	0.00425	0.00425	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—F2—liver cancer	0.00421	0.00421	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—liver cancer	0.0041	0.0041	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—liver cancer	0.00382	0.00382	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FST—liver cancer	0.00378	0.00378	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—liver cancer	0.00376	0.00376	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—liver cancer	0.00372	0.00372	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PRKCE—liver cancer	0.00371	0.00371	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TRIO—liver cancer	0.00361	0.00361	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SHC3—liver cancer	0.00354	0.00354	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FST—liver cancer	0.00349	0.00349	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR4—liver cancer	0.00346	0.00346	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PRKCE—liver cancer	0.00342	0.00342	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PRKCE—liver cancer	0.00337	0.00337	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TRIO—liver cancer	0.00333	0.00333	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—F2—liver cancer	0.00331	0.00331	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CSF2—liver cancer	0.00328	0.00328	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR4—liver cancer	0.00319	0.00319	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PRKCE—liver cancer	0.00311	0.00311	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CSF2—liver cancer	0.00303	0.00303	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—liver cancer	0.00301	0.00301	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CSF2—liver cancer	0.00298	0.00298	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—PIK3CA—liver cancer	0.00294	0.00294	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00286	0.00286	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CSF2—liver cancer	0.00275	0.00275	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FST—liver cancer	0.00275	0.00275	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADAM17—liver cancer	0.00273	0.00273	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PRKCE—liver cancer	0.0027	0.0027	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00263	0.00263	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TRIO—liver cancer	0.00262	0.00262	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—F2—liver cancer	0.00258	0.00258	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSMD10—liver cancer	0.00257	0.00257	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSMA4—liver cancer	0.00257	0.00257	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADAM17—liver cancer	0.00252	0.00252	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR4—liver cancer	0.00251	0.00251	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CG—liver cancer	0.00247	0.00247	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKCE—liver cancer	0.00245	0.00245	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00243	0.00243	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CSF2—liver cancer	0.00239	0.00239	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—F2—liver cancer	0.00238	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSMA4—liver cancer	0.00237	0.00237	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSMD10—liver cancer	0.00237	0.00237	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—F2—liver cancer	0.00234	0.00234	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.00232	0.00232	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CG—liver cancer	0.00227	0.00227	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CG—liver cancer	0.00224	0.00224	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CD—liver cancer	0.00217	0.00217	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CSF2—liver cancer	0.00217	0.00217	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—F2—liver cancer	0.00216	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—liver cancer	0.00207	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—liver cancer	0.002	0.002	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCE—liver cancer	0.00199	0.00199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADAM17—liver cancer	0.00199	0.00199	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—liver cancer	0.00197	0.00197	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—liver cancer	0.00189	0.00189	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF2—liver cancer	0.00189	0.00189	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—F2—liver cancer	0.00187	0.00187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSMA4—liver cancer	0.00187	0.00187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSMD10—liver cancer	0.00187	0.00187	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCE—liver cancer	0.00184	0.00184	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—liver cancer	0.00182	0.00182	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—liver cancer	0.00179	0.00179	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CSF2—liver cancer	0.00176	0.00176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RAF1—liver cancer	0.00176	0.00176	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—liver cancer	0.00174	0.00174	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF2—liver cancer	0.00174	0.00174	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—H2AFX—liver cancer	0.00174	0.00174	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—liver cancer	0.00173	0.00173	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—liver cancer	0.00172	0.00172	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—F2—liver cancer	0.0017	0.0017	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—liver cancer	0.00163	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CSF2—liver cancer	0.00163	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RAF1—liver cancer	0.00162	0.00162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—H2AFX—liver cancer	0.0016	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—liver cancer	0.0016	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—liver cancer	0.00158	0.00158	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—liver cancer	0.00158	0.00158	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—liver cancer	0.00157	0.00157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—liver cancer	0.00157	0.00157	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—liver cancer	0.00145	0.00145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—liver cancer	0.00145	0.00145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCE—liver cancer	0.00145	0.00145	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—liver cancer	0.00144	0.00144	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—liver cancer	0.00143	0.00143	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK14—liver cancer	0.00143	0.00143	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ESR1—liver cancer	0.0014	0.0014	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—F2—liver cancer	0.00138	0.00138	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—liver cancer	0.00137	0.00137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF2—liver cancer	0.00137	0.00137	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—liver cancer	0.00132	0.00132	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—liver cancer	0.00132	0.00132	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APC—liver cancer	0.00132	0.00132	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK14—liver cancer	0.00132	0.00132	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ESR1—liver cancer	0.00129	0.00129	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CSF2—liver cancer	0.00128	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAF1—liver cancer	0.00128	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—F2—liver cancer	0.00128	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—H2AFX—liver cancer	0.00126	0.00126	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—liver cancer	0.00126	0.00126	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—liver cancer	0.00125	0.00125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BRAF—liver cancer	0.00124	0.00124	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APC—liver cancer	0.00122	0.00122	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—liver cancer	0.00122	0.00122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—liver cancer	0.00116	0.00116	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—liver cancer	0.00115	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—liver cancer	0.00115	0.00115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BRAF—liver cancer	0.00115	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—liver cancer	0.00114	0.00114	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—liver cancer	0.00114	0.00114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—liver cancer	0.00114	0.00114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—liver cancer	0.00107	0.00107	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—liver cancer	0.00106	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—liver cancer	0.00106	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—liver cancer	0.00105	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—liver cancer	0.00105	0.00105	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—liver cancer	0.00104	0.00104	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAF1—liver cancer	0.00104	0.00104	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK14—liver cancer	0.00104	0.00104	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ESR1—liver cancer	0.00102	0.00102	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MTOR—liver cancer	0.00101	0.00101	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—liver cancer	0.00101	0.00101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2—liver cancer	0.001	0.001	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRAS—liver cancer	0.000967	0.000967	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—liver cancer	0.000965	0.000965	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APC—liver cancer	0.000961	0.000961	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—liver cancer	0.000961	0.000961	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAF1—liver cancer	0.000958	0.000958	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1B—liver cancer	0.000951	0.000951	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—liver cancer	0.000941	0.000941	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MTOR—liver cancer	0.000935	0.000935	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—liver cancer	0.000935	0.000935	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—liver cancer	0.000932	0.000932	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—liver cancer	0.000931	0.000931	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—liver cancer	0.000926	0.000926	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—liver cancer	0.000907	0.000907	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUN—liver cancer	0.000905	0.000905	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BRAF—liver cancer	0.000903	0.000903	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—liver cancer	0.000898	0.000898	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRAS—liver cancer	0.000893	0.000893	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—liver cancer	0.000881	0.000881	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—liver cancer	0.000878	0.000878	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1B—liver cancer	0.000878	0.000878	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—liver cancer	0.000868	0.000868	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—liver cancer	0.00086	0.00086	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—liver cancer	0.000859	0.000859	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK8—liver cancer	0.000857	0.000857	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—liver cancer	0.000855	0.000855	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—liver cancer	0.000854	0.000854	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—liver cancer	0.000845	0.000845	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—liver cancer	0.000837	0.000837	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000837	0.000837	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—liver cancer	0.000835	0.000835	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUN—liver cancer	0.000835	0.000835	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—liver cancer	0.000829	0.000829	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—liver cancer	0.000827	0.000827	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—liver cancer	0.000813	0.000813	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—liver cancer	0.00081	0.00081	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—liver cancer	0.000791	0.000791	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK8—liver cancer	0.00079	0.00079	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—liver cancer	0.000788	0.000788	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—liver cancer	0.000783	0.000783	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—liver cancer	0.00076	0.00076	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAF1—liver cancer	0.000754	0.000754	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MTOR—liver cancer	0.000736	0.000736	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—liver cancer	0.000736	0.000736	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—liver cancer	0.00073	0.00073	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—liver cancer	0.000728	0.000728	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—liver cancer	0.000726	0.000726	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—liver cancer	0.000723	0.000723	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRAS—liver cancer	0.000703	0.000703	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1B—liver cancer	0.000691	0.000691	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—liver cancer	0.000683	0.000683	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—liver cancer	0.000677	0.000677	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—liver cancer	0.000676	0.000676	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—liver cancer	0.000673	0.000673	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—liver cancer	0.000672	0.000672	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—liver cancer	0.000672	0.000672	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—liver cancer	0.00067	0.00067	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—liver cancer	0.000659	0.000659	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUN—liver cancer	0.000658	0.000658	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—liver cancer	0.000653	0.000653	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—liver cancer	0.00064	0.00064	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—liver cancer	0.000638	0.000638	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK8—liver cancer	0.000622	0.000622	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—liver cancer	0.000621	0.000621	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—liver cancer	0.00062	0.00062	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—liver cancer	0.000618	0.000618	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—liver cancer	0.000598	0.000598	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—liver cancer	0.000575	0.000575	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRAS—liver cancer	0.000571	0.000571	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—liver cancer	0.00057	0.00057	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—liver cancer	0.000569	0.000569	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—liver cancer	0.000551	0.000551	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—liver cancer	0.000547	0.000547	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—liver cancer	0.000529	0.000529	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—liver cancer	0.000527	0.000527	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRAS—liver cancer	0.000527	0.000527	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—liver cancer	0.000505	0.000505	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—liver cancer	0.000505	0.000505	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—liver cancer	0.000489	0.000489	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—liver cancer	0.000466	0.000466	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—liver cancer	0.000449	0.000449	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—liver cancer	0.000434	0.000434	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRAS—liver cancer	0.000415	0.000415	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—liver cancer	0.000397	0.000397	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—liver cancer	0.000367	0.000367	CbGpPWpGaD
